TY  - JOUR
AU  - Zeiser, Robert
AU  - Polverelli, Nicola
AU  - Ram, Ron
AU  - Hashmi, Shahrukh K
AU  - Chakraverty, Ronjon
AU  - Middeke, Jan Moritz
AU  - Musso, Maurizio
AU  - Giebel, Sebastian
AU  - Uzay, Ant
AU  - Langmuir, Peter
AU  - Hollaender, Norbert
AU  - Gowda, Maanasa
AU  - Stefanelli, Tommaso
AU  - Lee, Stephanie J
AU  - Teshima, Takanori
AU  - Locatelli, Franco
AU  - REACH3 Investigators
PY  - 2021
DO  - 10.1056/NEJMoa2033122
UR  - https://hdl.handle.net/10668/26682
T2  - The New England journal of medicine
AB  - Chronic graft-versus-host disease (GVHD), a major complication of allogeneic stem-cell transplantation, becomes glucocorticoid-refractory or glucocorticoid-dependent in approximately 50% of patients. Robust data from phase 3 randomized studies...
LA  - en
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Child
KW  - Cytomegalovirus Infections
KW  - Female
KW  - Glucocorticoids
KW  - Graft vs Host Disease
KW  - Humans
KW  - Immunologic Factors
KW  - Janus Kinases
KW  - Male
KW  - Middle Aged
KW  - Nitriles
KW  - Photopheresis
KW  - Pyrazoles
KW  - Pyrimidines
KW  - Survival Analysis
KW  - Thrombocytopenia
KW  - Treatment Failure
KW  - Young Adult
TI  - Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease.
TY  - research article
VL  - 385
ER  -